SG
NTUS

Societe Generale’s Natus Medical Inc NTUS Stock Holding History

Societe Generale’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$407K Buy
+10,767
New +$361K ﹤0.01% 1819

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Societe Generale's NTUS Position: Q2 2016 in Review

Societe Generale opened a new position in Natus Medical Inc (NTUS) in Q2 2016: 10,767 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #1819 among its holdings.

195 funds tracked by Wall St. Rank hold NTUS as of Q2 2016.

  • Societe Generale held 10,767 shares of Natus Medical Inc worth $407K as of Q2 2016.
  • Natus Medical Inc was a new Societe Generale position in Q2 2016.
  • Natus Medical Inc made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1819 holding.
  • 195 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.